Frank

@pdicarlotrader So basically your indicator will turn green at ATH? 🤣

Big week for $META with earnings Wed. Short-term trend still down. Monthly BX shows buyers, but price must break and hold above this smart money zone. If not, likely another trap. I’ll wait for a clear bullish flip before adding it back to the fund.

@Maximus_Holla tell me the truth... you do have a crystal ball...

$RR 👀

$ADBE nice gapper!

@BethNabu @TheLongInvest Many

@TheLongInvest Does anyone knows how many years can that take

$NVO can 10 X from here to complete a standard impulse count Buy at $40 and hold to $400. +5% Dividend

BEST TRADING TIMES YOU SHOULD KNOW 1️⃣ 9:15 am – 9:45 am — Momentum trading 2️⃣ 9:45 am – 11:00 am — Directional trading 3️⃣ 11:00 am – 12:00 pm — Range / sideways trading 4️⃣ 12:00 pm – 1:00 pm — Low volume, avoid overtrading 5️⃣ 1:00 pm – 2:00 pm — Steady price action 6️⃣ 2:00 pm – 3:00 pm — Trend continuation setups 7️⃣ 3:00 pm – 3:30 pm — Pre-close positioning 8️⃣ 3:30 pm – 4:00 pm — Power hour, strong moves 9️⃣ After hours — News reactions (higher risk) 🔟 Pre-market — Levels building, light volume Rule: Trade when the market moves, not when you’re bored.

Sunday 9pm , futures 😬

@TheStockDon $REMX is at all time high...

The plays and why: $MP — only domestic US rare earth miner/processor $USAR — vertically integrated mine-to-magnet, Round Top TX, Commerce Dept backed $CRML — Greenland HREE, dysprosium/terbium/yttrium $DTREF — gold + HREE California, Music Valley acquisition $NB — niobium/scandium/titanium, Pentagon-funded $UUUU — uranium + rare earth separation $URG $UEC — domestic uranium producers $ALB — most liquid lithium play $LAC — domestic lithium, Nevada $PPTA — antimony + gold, DoD contract $WWR — only domestic graphite processor $REMX — ETF basket, broadest exposure

@moonmarket News?

$AGAE volume uptick

@TheLongInvest Isnt the valuation still too high?

$NKE Tim Cook and $NKE CEO have both bought another $1 million worth of shares yesterday each This is just before the price action reaches the 'Impossible level to ignore' price at $39 I suspect they know something And they know good companies The issue for $NKE is whether or not you believe they can turn it around and do you have the capability to hold to see this happen? Tim Cook believes they can

@JLfitnessinph @TheLongInvest I was like that... until i entered $unh 🫠

@TheLongInvest 🤷‍♂️ outperforming a bit

In the summer of ‘25, everyone wanted +100% gains in 1 month In 2026, everyone just wants to beat the market The market will humble you if you are not prepared You deploy your cash in a bear market You build your cash up towards the end of a bull market. I can’t believe how hard it was to convey this message at the time.

@Maximus_Holla Pumpola wednesday!!

Pump it!

@Maximus_Holla news?

$ENVX

@pdicarlotrader How about selling Cash secure puts?

$MSFT monthly bx is still red. Not buying yet. That said long term institutional support is holding up well. 80% of the time price bounces off this level. This is a strong long term entry zone. ✅ When the monthly flips I will be ready to move.

@TheLongInvest the moat is not longer valid

$PYPL Price is still at $44, where it was in 2017 Revenue was $3 Billion then Revenue is $8.7 Billion now What does it need to do to turn this around?

@TheLongInvest $MELI

I think it's time to do another 5 Year Projection chart Share the ticker below that you want to see and like this post.

We – design the chips & hardware – make the cars w/ said hardware – collect real-world data at scale – train the real-world AI model – built (& continue to expand) the massive supercomputer cluster that trains it – deploy AI directly to millions of robots on wheels All that is shared with @Tesla_Optimus for broader applications in both the physical & digital world

@TheLongInvest what about fundamentals?

$ASTS Hold above $104 and this can go to $175 Currently at $92

We founded Hims & Hers to help more people feel great. To disrupt a broken healthcare system and create a new model of health where innovators work together to deliver access to care that actually serves everyday people. We align how we operate with where we see major growth opportunities and in a way that allows us to meet our customers where they are (and where they want to go). That’s why, later this month, Hims & Hers customers will have access to FDA-approved medications from @novonordisk as a part of a strategic collaboration. The weight loss landscape is completely different today than it was when we first entered the category. FDA-approved GLP-1 treatments are now more accessible, with greater affordability and more flexible dosing options and form factors. These market changes are shifting consumer demand towards these branded medications. We’re moving our model forward another step with this strategic shift in our US weight loss business. This evolution will make us the largest global consumer health platform providing access to more affordable, approved medications. We will continue to innovate across our platform, keeping what’s best for consumers as our North Star. There's challenging, important work in front of us, and I've never been more excited about the path ahead. Just like we always do, Hims & Hers will rise to meet the moment. More here: investors.hims.com/news/news-deta… Important info here: news.hims.com/disclaimers/di…

@devineni6 @TheLongInvest On top...

@TheLongInvest Where’s $UNH?

You beat everyone for the next 5 years with this: US Market: $ZETA $UNH $HIMS $GOOG & $NVDA (after they correct) CHINA: $BABA $BIDU $JD BONDS: $TLT EMERGING MARKETS: $EWZ $SE $GRAB CRYPTO: $ETH $BTC EUROPE: $ASML $NVO DIVIDEND: $UPS $PFE DATA: $NBIS $AMD $DELL SAAS: $NOW $ORCL BIO: $TMDX CONSUMER: $LULU $NKE $ONON FINTECH: $SOFI $NU DISRUPT: $OSCR $HOOD $ONDS MOAT: $ASTS $ADUR

$HIMS 👀